82 related articles for article (PubMed ID: 1535220)
1. Indirect presentation of donor histocompatibility antigens contributes to the allogeneic response against human cardiac myocytes.
Ansari AA; Wang YC; Kanter K; Naucke N; Sell KW
J Heart Lung Transplant; 1992; 11(3 Pt 1):467-77; discussion 477-8. PubMed ID: 1535220
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex-expressing human cardiac myocytes are not the direct target of host cardiac-infiltrating cells: evidence for a prominent role of the indirect pathway in human cardiac allograft rejection.
Ansari AA; Kanter K; Wang YC; Mayne A; Sell KW; Herskowitz A
Transplant Proc; 1993 Feb; 25(1 Pt 1):89-93. PubMed ID: 8438502
[No Abstract] [Full Text] [Related]
4. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human heart-infiltrating cells after transplantation. VI. Differences in the cytokines produced by individual CD4+ cloned T-cell lines with apparently identical antiidiotype-like reactivity.
Sell KW; Wang YC; Kanter K; Rodey GE; Mayne A; Ansari AA
J Heart Lung Transplant; 1992; 11(3 Pt 1):511-21. PubMed ID: 1351745
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of human cardiac allograft rejection: absence of co-stimulatory molecules and cell adhesion molecules on major histocompatibility complex class I/II+ human cardiac myocytes does not induce anergy.
Sundstrom JB; Mayne A; Kanter K; Herskowitz A; Ansari AA
Transplant Proc; 1995 Feb; 27(1):1310-3. PubMed ID: 7878895
[No Abstract] [Full Text] [Related]
7. Characterization of human heart-infiltrating cells after transplantation. V. Suppression of donor-specific allogeneic responses by cloned T-cell lines isolated from heart biopsy specimens of patients after transplantation.
Sell KW; Kanter K; Rodey GE; Wang YC; Ansari AA
J Heart Lung Transplant; 1992; 11(3 Pt 1):500-10. PubMed ID: 1351744
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
9. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
10. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
Moreno J; Lipsky PE
J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
[TBL] [Abstract][Full Text] [Related]
11. Human T lymphocyte proliferative response to resting porcine endothelial cells results from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial-specific costimulatory factors.
Vallée I; Guillaumin JM; Thibault G; Gruel Y; Lebranchu Y; Bardos P; Watier H
J Immunol; 1998 Aug; 161(4):1652-8. PubMed ID: 9712027
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
14. Endothelial and smooth muscle cells in the heart allograft response: isolation procedure and immunocytochemical features.
Wijngaard PL; de Bresser JM; de Groot PG; Gmelig-Meyling FH; Schuurman HJ; Jambroes G; Borleffs JC
J Heart Lung Transplant; 1991; 10(3):416-23. PubMed ID: 1830221
[TBL] [Abstract][Full Text] [Related]
15. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
16. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
18. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
19. Expression of major histocompatibility complex antigens and induction of human T-lymphocyte proliferation by astrocytes and macrophages from porcine fetal brain.
Brevig T; Kristensen T; Zimmer J
Exp Neurol; 1999 Oct; 159(2):474-83. PubMed ID: 10506518
[TBL] [Abstract][Full Text] [Related]
20. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
Geppert TD; Lipsky PE
J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
